Table of Content

1 Influenzavirus B Infection Drug Market Overview
1.1 Influenzavirus B Infection Drug Product Scope
1.2 Influenzavirus B Infection Drug Segment by Type
1.2.1 Global Influenzavirus B Infection Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 APP-309
1.2.3 CF-403
1.2.4 GC-3106A
1.2.5 KIN-1400
1.2.6 Others
1.3 Influenzavirus B Infection Drug Segment by Application
1.3.1 Global Influenzavirus B Infection Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Influenzavirus B Infection Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Influenzavirus B Infection Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Influenzavirus B Infection Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Influenzavirus B Infection Drug Price Trends (2016-2027)

2 Influenzavirus B Infection Drug Estimates and Forecasts by Region
2.1 Global Influenzavirus B Infection Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Influenzavirus B Infection Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Influenzavirus B Infection Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Influenzavirus B Infection Drug Revenue Market Share by Region (2016-2021)
2.3 Global Influenzavirus B Infection Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Influenzavirus B Infection Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Influenzavirus B Infection Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Influenzavirus B Infection Drug Estimates and Projections (2016-2027)
2.4.2 Europe Influenzavirus B Infection Drug Estimates and Projections (2016-2027)
2.4.3 China Influenzavirus B Infection Drug Estimates and Projections (2016-2027)
2.4.4 Japan Influenzavirus B Infection Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Influenzavirus B Infection Drug Estimates and Projections (2016-2027)
2.4.6 India Influenzavirus B Infection Drug Estimates and Projections (2016-2027)

3 Global Influenzavirus B Infection Drug Competition Landscape by Players
3.1 Global Top Influenzavirus B Infection Drug Players by Sales (2016-2021)
3.2 Global Top Influenzavirus B Infection Drug Players by Revenue (2016-2021)
3.3 Global Influenzavirus B Infection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenzavirus B Infection Drug as of 2020)
3.4 Global Influenzavirus B Infection Drug Average Price by Company (2016-2021)
3.5 Manufacturers Influenzavirus B Infection Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Influenzavirus B Infection Drug Market Size by Type
4.1 Global Influenzavirus B Infection Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Influenzavirus B Infection Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Influenzavirus B Infection Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Influenzavirus B Infection Drug Price by Type (2016-2021)
4.2 Global Influenzavirus B Infection Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Influenzavirus B Infection Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Influenzavirus B Infection Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Influenzavirus B Infection Drug Price Forecast by Type (2022-2027)

5 Global Influenzavirus B Infection Drug Market Size by Application
5.1 Global Influenzavirus B Infection Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Influenzavirus B Infection Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Influenzavirus B Infection Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Influenzavirus B Infection Drug Price by Application (2016-2021)
5.2 Global Influenzavirus B Infection Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Influenzavirus B Infection Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Influenzavirus B Infection Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Influenzavirus B Infection Drug Price Forecast by Application (2022-2027)

6 North America Influenzavirus B Infection Drug Market Facts & Figures
6.1 North America Influenzavirus B Infection Drug Sales by Company
6.1.1 North America Influenzavirus B Infection Drug Sales by Company (2016-2021)
6.1.2 North America Influenzavirus B Infection Drug Revenue by Company (2016-2021)
6.2 North America Influenzavirus B Infection Drug Sales Breakdown by Type
6.2.1 North America Influenzavirus B Infection Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Influenzavirus B Infection Drug Sales Breakdown by Type (2022-2027)
6.3 North America Influenzavirus B Infection Drug Sales Breakdown by Application
6.3.1 North America Influenzavirus B Infection Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Influenzavirus B Infection Drug Sales Breakdown by Application (2022-2027)

7 Europe Influenzavirus B Infection Drug Market Facts & Figures
7.1 Europe Influenzavirus B Infection Drug Sales by Company
7.1.1 Europe Influenzavirus B Infection Drug Sales by Company (2016-2021)
7.1.2 Europe Influenzavirus B Infection Drug Revenue by Company (2016-2021)
7.2 Europe Influenzavirus B Infection Drug Sales Breakdown by Type
7.2.1 Europe Influenzavirus B Infection Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Influenzavirus B Infection Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Influenzavirus B Infection Drug Sales Breakdown by Application
7.3.1 Europe 153 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 153 Sales Breakdown by Application (2022-2027)

8 China Influenzavirus B Infection Drug Market Facts & Figures
8.1 China Influenzavirus B Infection Drug Sales by Company
8.1.1 China Influenzavirus B Infection Drug Sales by Company (2016-2021)
8.1.2 China Influenzavirus B Infection Drug Revenue by Company (2016-2021)
8.2 China Influenzavirus B Infection Drug Sales Breakdown by Type
8.2.1 China Influenzavirus B Infection Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Influenzavirus B Infection Drug Sales Breakdown by Type (2022-2027)
8.3 China Influenzavirus B Infection Drug Sales Breakdown by Application
8.3.1 China 175 Sales Breakdown by Application (2016-2021)
8.3.2 China 175 Sales Breakdown by Application (2022-2027)

9 Japan Influenzavirus B Infection Drug Market Facts & Figures
9.1 Japan Influenzavirus B Infection Drug Sales by Company
9.1.1 Japan Influenzavirus B Infection Drug Sales by Company (2016-2021)
9.1.2 Japan Influenzavirus B Infection Drug Revenue by Company (2016-2021)
9.2 Japan Influenzavirus B Infection Drug Sales Breakdown by Type
9.2.1 Japan Influenzavirus B Infection Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Influenzavirus B Infection Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Influenzavirus B Infection Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Influenzavirus B Infection Drug Market Facts & Figures
10.1 Southeast Asia Influenzavirus B Infection Drug Sales by Company
10.1.1 Southeast Asia Influenzavirus B Infection Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Influenzavirus B Infection Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Influenzavirus B Infection Drug Sales Breakdown by Type
10.2.1 Southeast Asia Influenzavirus B Infection Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Influenzavirus B Infection Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Influenzavirus B Infection Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Influenzavirus B Infection Drug Market Facts & Figures
11.1 India Influenzavirus B Infection Drug Sales by Company
11.1.1 India Influenzavirus B Infection Drug Sales by Company (2016-2021)
11.1.2 India Influenzavirus B Infection Drug Revenue by Company (2016-2021)
11.2 India Influenzavirus B Infection Drug Sales Breakdown by Type
11.2.1 India Influenzavirus B Infection Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Influenzavirus B Infection Drug Sales Breakdown by Type (2022-2027)
11.3 India Influenzavirus B Infection Drug Sales Breakdown by Application
11.3.1 India Influenzavirus B Infection Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Influenzavirus B Infection Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Influenzavirus B Infection Drug Business
12.1 AbbVie Inc
12.1.1 AbbVie Inc Corporation Information
12.1.2 AbbVie Inc Business Overview
12.1.3 AbbVie Inc Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AbbVie Inc Influenzavirus B Infection Drug Products Offered
12.1.5 AbbVie Inc Recent Development
12.2 Adimmune Corp
12.2.1 Adimmune Corp Corporation Information
12.2.2 Adimmune Corp Business Overview
12.2.3 Adimmune Corp Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Adimmune Corp Influenzavirus B Infection Drug Products Offered
12.2.5 Adimmune Corp Recent Development
12.3 Altravax Inc
12.3.1 Altravax Inc Corporation Information
12.3.2 Altravax Inc Business Overview
12.3.3 Altravax Inc Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Altravax Inc Influenzavirus B Infection Drug Products Offered
12.3.5 Altravax Inc Recent Development
12.4 Amarillo Biosciences Inc
12.4.1 Amarillo Biosciences Inc Corporation Information
12.4.2 Amarillo Biosciences Inc Business Overview
12.4.3 Amarillo Biosciences Inc Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Amarillo Biosciences Inc Influenzavirus B Infection Drug Products Offered
12.4.5 Amarillo Biosciences Inc Recent Development
12.5 Aphios Corp
12.5.1 Aphios Corp Corporation Information
12.5.2 Aphios Corp Business Overview
12.5.3 Aphios Corp Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Aphios Corp Influenzavirus B Infection Drug Products Offered
12.5.5 Aphios Corp Recent Development
12.6 BioCryst Pharmaceuticals Inc
12.6.1 BioCryst Pharmaceuticals Inc Corporation Information
12.6.2 BioCryst Pharmaceuticals Inc Business Overview
12.6.3 BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Products Offered
12.6.5 BioCryst Pharmaceuticals Inc Recent Development
12.7 Cadila Healthcare Ltd
12.7.1 Cadila Healthcare Ltd Corporation Information
12.7.2 Cadila Healthcare Ltd Business Overview
12.7.3 Cadila Healthcare Ltd Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Cadila Healthcare Ltd Influenzavirus B Infection Drug Products Offered
12.7.5 Cadila Healthcare Ltd Recent Development
12.8 ContraFect Corp
12.8.1 ContraFect Corp Corporation Information
12.8.2 ContraFect Corp Business Overview
12.8.3 ContraFect Corp Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 ContraFect Corp Influenzavirus B Infection Drug Products Offered
12.8.5 ContraFect Corp Recent Development
12.9 Daiichi Sankyo Company Ltd
12.9.1 Daiichi Sankyo Company Ltd Corporation Information
12.9.2 Daiichi Sankyo Company Ltd Business Overview
12.9.3 Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Products Offered
12.9.5 Daiichi Sankyo Company Ltd Recent Development
12.10 Fujifilm Holdings Corporation
12.10.1 Fujifilm Holdings Corporation Corporation Information
12.10.2 Fujifilm Holdings Corporation Business Overview
12.10.3 Fujifilm Holdings Corporation Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Fujifilm Holdings Corporation Influenzavirus B Infection Drug Products Offered
12.10.5 Fujifilm Holdings Corporation Recent Development
12.11 GlaxoSmithKline Plc
12.11.1 GlaxoSmithKline Plc Corporation Information
12.11.2 GlaxoSmithKline Plc Business Overview
12.11.3 GlaxoSmithKline Plc Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GlaxoSmithKline Plc Influenzavirus B Infection Drug Products Offered
12.11.5 GlaxoSmithKline Plc Recent Development
12.12 Green Cross Corp
12.12.1 Green Cross Corp Corporation Information
12.12.2 Green Cross Corp Business Overview
12.12.3 Green Cross Corp Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Green Cross Corp Influenzavirus B Infection Drug Products Offered
12.12.5 Green Cross Corp Recent Development
12.13 Inovio Pharmaceuticals Inc
12.13.1 Inovio Pharmaceuticals Inc Corporation Information
12.13.2 Inovio Pharmaceuticals Inc Business Overview
12.13.3 Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Products Offered
12.13.5 Inovio Pharmaceuticals Inc Recent Development
12.14 Kineta Inc
12.14.1 Kineta Inc Corporation Information
12.14.2 Kineta Inc Business Overview
12.14.3 Kineta Inc Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Kineta Inc Influenzavirus B Infection Drug Products Offered
12.14.5 Kineta Inc Recent Development
12.15 Medicago Inc
12.15.1 Medicago Inc Corporation Information
12.15.2 Medicago Inc Business Overview
12.15.3 Medicago Inc Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Medicago Inc Influenzavirus B Infection Drug Products Offered
12.15.5 Medicago Inc Recent Development
12.16 MedImmune LLC
12.16.1 MedImmune LLC Corporation Information
12.16.2 MedImmune LLC Business Overview
12.16.3 MedImmune LLC Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.16.4 MedImmune LLC Influenzavirus B Infection Drug Products Offered
12.16.5 MedImmune LLC Recent Development
12.17 Mucosis BV
12.17.1 Mucosis BV Corporation Information
12.17.2 Mucosis BV Business Overview
12.17.3 Mucosis BV Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Mucosis BV Influenzavirus B Infection Drug Products Offered
12.17.5 Mucosis BV Recent Development
12.18 Novavax Inc
12.18.1 Novavax Inc Corporation Information
12.18.2 Novavax Inc Business Overview
12.18.3 Novavax Inc Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Novavax Inc Influenzavirus B Infection Drug Products Offered
12.18.5 Novavax Inc Recent Development
12.19 Park Active Molecules
12.19.1 Park Active Molecules Corporation Information
12.19.2 Park Active Molecules Business Overview
12.19.3 Park Active Molecules Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Park Active Molecules Influenzavirus B Infection Drug Products Offered
12.19.5 Park Active Molecules Recent Development
12.20 Romark Laboratories LC
12.20.1 Romark Laboratories LC Corporation Information
12.20.2 Romark Laboratories LC Business Overview
12.20.3 Romark Laboratories LC Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Romark Laboratories LC Influenzavirus B Infection Drug Products Offered
12.20.5 Romark Laboratories LC Recent Development
12.21 Sanofi
12.21.1 Sanofi Corporation Information
12.21.2 Sanofi Business Overview
12.21.3 Sanofi Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Sanofi Influenzavirus B Infection Drug Products Offered
12.21.5 Sanofi Recent Development
12.22 Sanofi Pasteur SA
12.22.1 Sanofi Pasteur SA Corporation Information
12.22.2 Sanofi Pasteur SA Business Overview
12.22.3 Sanofi Pasteur SA Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Sanofi Pasteur SA Influenzavirus B Infection Drug Products Offered
12.22.5 Sanofi Pasteur SA Recent Development
12.23 Shionogi & Co Ltd
12.23.1 Shionogi & Co Ltd Corporation Information
12.23.2 Shionogi & Co Ltd Business Overview
12.23.3 Shionogi & Co Ltd Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Shionogi & Co Ltd Influenzavirus B Infection Drug Products Offered
12.23.5 Shionogi & Co Ltd Recent Development
12.24 SK Chemicals Co Ltd
12.24.1 SK Chemicals Co Ltd Corporation Information
12.24.2 SK Chemicals Co Ltd Business Overview
12.24.3 SK Chemicals Co Ltd Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.24.4 SK Chemicals Co Ltd Influenzavirus B Infection Drug Products Offered
12.24.5 SK Chemicals Co Ltd Recent Development
12.25 TSRL Inc
12.25.1 TSRL Inc Corporation Information
12.25.2 TSRL Inc Business Overview
12.25.3 TSRL Inc Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.25.4 TSRL Inc Influenzavirus B Infection Drug Products Offered
12.25.5 TSRL Inc Recent Development
12.26 Vaxart Inc
12.26.1 Vaxart Inc Corporation Information
12.26.2 Vaxart Inc Business Overview
12.26.3 Vaxart Inc Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.26.4 Vaxart Inc Influenzavirus B Infection Drug Products Offered
12.26.5 Vaxart Inc Recent Development
12.27 Vectura Group Plc
12.27.1 Vectura Group Plc Corporation Information
12.27.2 Vectura Group Plc Business Overview
12.27.3 Vectura Group Plc Influenzavirus B Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.27.4 Vectura Group Plc Influenzavirus B Infection Drug Products Offered
12.27.5 Vectura Group Plc Recent Development

13 Influenzavirus B Infection Drug Manufacturing Cost Analysis
13.1 Influenzavirus B Infection Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Influenzavirus B Infection Drug
13.4 Influenzavirus B Infection Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Influenzavirus B Infection Drug Distributors List
14.3 Influenzavirus B Infection Drug Customers

15 Market Dynamics
15.1 Influenzavirus B Infection Drug Market Trends
15.2 Influenzavirus B Infection Drug Drivers
15.3 Influenzavirus B Infection Drug Market Challenges
15.4 Influenzavirus B Infection Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Influenzavirus B Infection Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Influenzavirus B Infection Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Influenzavirus B Infection Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Influenzavirus B Infection Drug Sales (K Pcs) by Region (2016-2021)
Table 5. Global Influenzavirus B Infection Drug Sales Market Share by Region (2016-2021)
Table 6. Global Influenzavirus B Infection Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Influenzavirus B Infection Drug Revenue Share by Region (2016-2021)
Table 8. Global Influenzavirus B Infection Drug Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Influenzavirus B Infection Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Influenzavirus B Infection Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Influenzavirus B Infection Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Influenzavirus B Infection Drug Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Influenzavirus B Infection Drug Sales Share by Company (2016-2021)
Table 14. Global Influenzavirus B Infection Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Influenzavirus B Infection Drug Revenue Share by Company (2016-2021)
Table 16. Global Influenzavirus B Infection Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenzavirus B Infection Drug as of 2020)
Table 17. Global Influenzavirus B Infection Drug Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Influenzavirus B Infection Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Influenzavirus B Infection Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Influenzavirus B Infection Drug Sales (K Pcs) by Type (2016-2021)
Table 22. Global Influenzavirus B Infection Drug Sales Share by Type (2016-2021)
Table 23. Global Influenzavirus B Infection Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Influenzavirus B Infection Drug Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Influenzavirus B Infection Drug Sales Share by Type (2022-2027)
Table 26. Global Influenzavirus B Infection Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Influenzavirus B Infection Drug Revenue Share by Type (2022-2027)
Table 28. Global Influenzavirus B Infection Drug Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Influenzavirus B Infection Drug Sales (K Pcs) by Application (2016-2021)
Table 30. Global Influenzavirus B Infection Drug Sales Share by Application (2016-2021)
Table 31. Global Influenzavirus B Infection Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Influenzavirus B Infection Drug Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Influenzavirus B Infection Drug Sales (K Pcs) by Application (2022-2027)
Table 34. Global Influenzavirus B Infection Drug Sales Share by Application (2022-2027)
Table 35. Global Influenzavirus B Infection Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Influenzavirus B Infection Drug Revenue Share by Application (2022-2027)
Table 37. Global Influenzavirus B Infection Drug Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Influenzavirus B Infection Drug Sales (K Pcs) by Company (2016-2021)
Table 39. North America Influenzavirus B Infection Drug Sales Market Share by Company (2016-2021)
Table 40. North America Influenzavirus B Infection Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Influenzavirus B Infection Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Influenzavirus B Infection Drug Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Influenzavirus B Infection Drug Sales Market Share by Type (2016-2021)
Table 44. North America Influenzavirus B Infection Drug Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Influenzavirus B Infection Drug Sales Market Share by Type (2022-2027)
Table 46. North America Influenzavirus B Infection Drug Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Influenzavirus B Infection Drug Sales Market Share by Application (2016-2021)
Table 48. North America Influenzavirus B Infection Drug Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Influenzavirus B Infection Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Influenzavirus B Infection Drug Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Influenzavirus B Infection Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Influenzavirus B Infection Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Influenzavirus B Infection Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Influenzavirus B Infection Drug Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Influenzavirus B Infection Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Influenzavirus B Infection Drug Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Influenzavirus B Infection Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Influenzavirus B Infection Drug Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Influenzavirus B Infection Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Influenzavirus B Infection Drug Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Influenzavirus B Infection Drug Sales Market Share by Application (2022-2027)
Table 62. China Influenzavirus B Infection Drug Sales (K Pcs) by Company (2016-2021)
Table 63. China Influenzavirus B Infection Drug Sales Market Share by Company (2016-2021)
Table 64. China Influenzavirus B Infection Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Influenzavirus B Infection Drug Revenue Market Share by Company (2016-2021)
Table 66. China Influenzavirus B Infection Drug Sales by Type (2016-2021) & (K Pcs)
Table 67. China Influenzavirus B Infection Drug Sales Market Share by Type (2016-2021)
Table 68. China Influenzavirus B Infection Drug Sales by Type (2022-2027) & (K Pcs)
Table 69. China Influenzavirus B Infection Drug Sales Market Share by Type (2022-2027)
Table 70. China Influenzavirus B Infection Drug Sales by Application (2016-2021) & (K Pcs)
Table 71. China Influenzavirus B Infection Drug Sales Market Share by Application (2016-2021)
Table 72. China Influenzavirus B Infection Drug Sales by Application (2022-2027) & (K Pcs)
Table 73. China Influenzavirus B Infection Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Influenzavirus B Infection Drug Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Influenzavirus B Infection Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Influenzavirus B Infection Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Influenzavirus B Infection Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Influenzavirus B Infection Drug Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Influenzavirus B Infection Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Influenzavirus B Infection Drug Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Influenzavirus B Infection Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Influenzavirus B Infection Drug Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Influenzavirus B Infection Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Influenzavirus B Infection Drug Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Influenzavirus B Infection Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Influenzavirus B Infection Drug Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Influenzavirus B Infection Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Influenzavirus B Infection Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Influenzavirus B Infection Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Influenzavirus B Infection Drug Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Influenzavirus B Infection Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Influenzavirus B Infection Drug Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Influenzavirus B Infection Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Influenzavirus B Infection Drug Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Influenzavirus B Infection Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Influenzavirus B Infection Drug Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Influenzavirus B Infection Drug Sales Market Share by Application (2022-2027)
Table 98. India Influenzavirus B Infection Drug Sales (K Pcs) by Company (2016-2021)
Table 99. India Influenzavirus B Infection Drug Sales Market Share by Company (2016-2021)
Table 100. India Influenzavirus B Infection Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Influenzavirus B Infection Drug Revenue Market Share by Company (2016-2021)
Table 102. India Influenzavirus B Infection Drug Sales by Type (2016-2021) & (K Pcs)
Table 103. India Influenzavirus B Infection Drug Sales Market Share by Type (2016-2021)
Table 104. India Influenzavirus B Infection Drug Sales by Type (2022-2027) & (K Pcs)
Table 105. India Influenzavirus B Infection Drug Sales Market Share by Type (2022-2027)
Table 106. India Influenzavirus B Infection Drug Sales by Application (2016-2021) & (K Pcs)
Table 107. India Influenzavirus B Infection Drug Sales Market Share by Application (2016-2021)
Table 108. India Influenzavirus B Infection Drug Sales by Application (2022-2027) & (K Pcs)
Table 109. India Influenzavirus B Infection Drug Sales Market Share by Application (2022-2027)
Table 110. AbbVie Inc Corporation Information
Table 111. AbbVie Inc Description and Business Overview
Table 112. AbbVie Inc Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. AbbVie Inc Influenzavirus B Infection Drug Product
Table 114. AbbVie Inc Recent Development
Table 115. Adimmune Corp Corporation Information
Table 116. Adimmune Corp Description and Business Overview
Table 117. Adimmune Corp Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Adimmune Corp Influenzavirus B Infection Drug Product
Table 119. Adimmune Corp Recent Development
Table 120. Altravax Inc Corporation Information
Table 121. Altravax Inc Description and Business Overview
Table 122. Altravax Inc Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Altravax Inc Influenzavirus B Infection Drug Product
Table 124. Altravax Inc Recent Development
Table 125. Amarillo Biosciences Inc Corporation Information
Table 126. Amarillo Biosciences Inc Description and Business Overview
Table 127. Amarillo Biosciences Inc Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Amarillo Biosciences Inc Influenzavirus B Infection Drug Product
Table 129. Amarillo Biosciences Inc Recent Development
Table 130. Aphios Corp Corporation Information
Table 131. Aphios Corp Description and Business Overview
Table 132. Aphios Corp Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Aphios Corp Influenzavirus B Infection Drug Product
Table 134. Aphios Corp Recent Development
Table 135. BioCryst Pharmaceuticals Inc Corporation Information
Table 136. BioCryst Pharmaceuticals Inc Description and Business Overview
Table 137. BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Product
Table 139. BioCryst Pharmaceuticals Inc Recent Development
Table 140. Cadila Healthcare Ltd Corporation Information
Table 141. Cadila Healthcare Ltd Description and Business Overview
Table 142. Cadila Healthcare Ltd Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Cadila Healthcare Ltd Influenzavirus B Infection Drug Product
Table 144. Cadila Healthcare Ltd Recent Development
Table 145. ContraFect Corp Corporation Information
Table 146. ContraFect Corp Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. ContraFect Corp Description and Business Overview
Table 148. ContraFect Corp Influenzavirus B Infection Drug Product
Table 149. ContraFect Corp Recent Development
Table 150. Daiichi Sankyo Company Ltd Corporation Information
Table 151. Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Daiichi Sankyo Company Ltd Description and Business Overview
Table 153. Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Product
Table 154. Daiichi Sankyo Company Ltd Recent Development
Table 155. Fujifilm Holdings Corporation Corporation Information
Table 156. Fujifilm Holdings Corporation Description and Business Overview
Table 157. Fujifilm Holdings Corporation Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Fujifilm Holdings Corporation Influenzavirus B Infection Drug Product
Table 159. Fujifilm Holdings Corporation Recent Development
Table 160. GlaxoSmithKline Plc Corporation Information
Table 161. GlaxoSmithKline Plc Description and Business Overview
Table 162. GlaxoSmithKline Plc Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. GlaxoSmithKline Plc Influenzavirus B Infection Drug Product
Table 164. GlaxoSmithKline Plc Recent Development
Table 165. Green Cross Corp Corporation Information
Table 166. Green Cross Corp Description and Business Overview
Table 167. Green Cross Corp Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Green Cross Corp Influenzavirus B Infection Drug Product
Table 169. Green Cross Corp Recent Development
Table 170. Inovio Pharmaceuticals Inc Corporation Information
Table 171. Inovio Pharmaceuticals Inc Description and Business Overview
Table 172. Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Product
Table 174. Inovio Pharmaceuticals Inc Recent Development
Table 175. Kineta Inc Corporation Information
Table 176. Kineta Inc Description and Business Overview
Table 177. Kineta Inc Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. Kineta Inc Influenzavirus B Infection Drug Product
Table 179. Kineta Inc Recent Development
Table 180. Medicago Inc Corporation Information
Table 181. Medicago Inc Description and Business Overview
Table 182. Medicago Inc Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 183. Medicago Inc Influenzavirus B Infection Drug Product
Table 184. Medicago Inc Recent Development
Table 185. MedImmune LLC Corporation Information
Table 186. MedImmune LLC Description and Business Overview
Table 187. MedImmune LLC Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 188. MedImmune LLC Influenzavirus B Infection Drug Product
Table 189. MedImmune LLC Recent Development
Table 190. Mucosis BV Corporation Information
Table 191. Mucosis BV Description and Business Overview
Table 192. Mucosis BV Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 193. Mucosis BV Influenzavirus B Infection Drug Product
Table 194. Mucosis BV Recent Development
Table 195. Novavax Inc Corporation Information
Table 196. Novavax Inc Description and Business Overview
Table 197. Novavax Inc Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 198. Novavax Inc Influenzavirus B Infection Drug Product
Table 199. Novavax Inc Recent Development
Table 200. Park Active Molecules Corporation Information
Table 201. Park Active Molecules Description and Business Overview
Table 202. Park Active Molecules Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 203. Park Active Molecules Influenzavirus B Infection Drug Product
Table 204. Park Active Molecules Recent Development
Table 205. Romark Laboratories LC Corporation Information
Table 206. Romark Laboratories LC Description and Business Overview
Table 207. Romark Laboratories LC Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 208. Romark Laboratories LC Influenzavirus B Infection Drug Product
Table 209. Romark Laboratories LC Recent Development
Table 210. Sanofi Corporation Information
Table 211. Sanofi Description and Business Overview
Table 212. Sanofi Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 213. Sanofi Influenzavirus B Infection Drug Product
Table 214. Sanofi Recent Development
Table 215. Sanofi Pasteur SA Corporation Information
Table 216. Sanofi Pasteur SA Description and Business Overview
Table 217. Sanofi Pasteur SA Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 218. Sanofi Pasteur SA Influenzavirus B Infection Drug Product
Table 219. Sanofi Pasteur SA Recent Development
Table 220. Shionogi & Co Ltd Corporation Information
Table 221. Shionogi & Co Ltd Description and Business Overview
Table 222. Shionogi & Co Ltd Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 223. Shionogi & Co Ltd Influenzavirus B Infection Drug Product
Table 224. Shionogi & Co Ltd Recent Development
Table 225. SK Chemicals Co Ltd Corporation Information
Table 226. SK Chemicals Co Ltd Description and Business Overview
Table 227. SK Chemicals Co Ltd Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 228. SK Chemicals Co Ltd Influenzavirus B Infection Drug Product
Table 229. SK Chemicals Co Ltd Recent Development
Table 230. TSRL Inc Corporation Information
Table 231. TSRL Inc Description and Business Overview
Table 232. TSRL Inc Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 233. TSRL Inc Influenzavirus B Infection Drug Product
Table 234. TSRL Inc Recent Development
Table 235. Vaxart Inc Corporation Information
Table 236. Vaxart Inc Description and Business Overview
Table 237. Vaxart Inc Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 238. Vaxart Inc Influenzavirus B Infection Drug Product
Table 239. Vaxart Inc Recent Development
Table 240. Vectura Group Plc Corporation Information
Table 241. Vectura Group Plc Description and Business Overview
Table 242. Vectura Group Plc Influenzavirus B Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 243. Vectura Group Plc Influenzavirus B Infection Drug Product
Table 244. Vectura Group Plc Recent Development
Table 245. Production Base and Market Concentration Rate of Raw Material
Table 246. Key Suppliers of Raw Materials
Table 247. Influenzavirus B Infection Drug Distributors List
Table 248. Influenzavirus B Infection Drug Customers List
Table 249. Influenzavirus B Infection Drug Market Trends
Table 250. Influenzavirus B Infection Drug Market Drivers
Table 251. Influenzavirus B Infection Drug Market Challenges
Table 252. Influenzavirus B Infection Drug Market Restraints
Table 253. Research Programs/Design for This Report
Table 254. Key Data Information from Secondary Sources
Table 255. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenzavirus B Infection Drug Product Picture
Figure 2. Global Influenzavirus B Infection Drug Sales Market Share by Type in 2021 & 2027
Figure 3. APP-309 Product Picture
Figure 4. CF-403 Product Picture
Figure 5. GC-3106A Product Picture
Figure 6. KIN-1400 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Influenzavirus B Infection Drug Sales Market Share by Application in 2021 & 2027
Figure 9. Clinic Examples
Figure 10. Hospital Examples
Figure 11. Others Examples
Figure 12. Global Influenzavirus B Infection Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Influenzavirus B Infection Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 14. Global Influenzavirus B Infection Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 15. Global Influenzavirus B Infection Drug Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 16. Global Influenzavirus B Infection Drug Revenue Market Share by Region: 2016 VS 2021
Figure 17. Global Influenzavirus B Infection Drug Revenue Market Share by Region: 2021 VS 2027
Figure 18. North America Influenzavirus B Infection Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. North America Influenzavirus B Infection Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 20. Europe Influenzavirus B Infection Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Europe Influenzavirus B Infection Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 22. China Influenzavirus B Infection Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. China Influenzavirus B Infection Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 24. Japan Influenzavirus B Infection Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Japan Influenzavirus B Infection Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Influenzavirus B Infection Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Influenzavirus B Infection Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 28. India Influenzavirus B Infection Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. India Influenzavirus B Infection Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Global 5 Largest Influenzavirus B Infection Drug Players Market Share by Revenue in Influenzavirus B Infection Drug: 2016 & 2020
Figure 31. Influenzavirus B Infection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 32. Global Influenzavirus B Infection Drug Revenue Share by Type (2016-2021)
Figure 33. Global Influenzavirus B Infection Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Global Influenzavirus B Infection Drug Revenue Share by Application (2016-2021)
Figure 35. Global Influenzavirus B Infection Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Influenzavirus B Infection Drug Sales Market Share by Type in 2020
Figure 37. North America Influenzavirus B Infection Drug Sales Market Share by Application in 2020
Figure 38. Europe Influenzavirus B Infection Drug Sales Market Share by Type in 2020
Figure 39. Europe Influenzavirus B Infection Drug Sales Market Share by Application in 2020
Figure 40. China Influenzavirus B Infection Drug Sales Market Share by Type in 2020
Figure 41. China Influenzavirus B Infection Drug Sales Market Share by Application in 2020
Figure 42. Japan Influenzavirus B Infection Drug Sales Market Share by Type in 2020
Figure 43. Japan Influenzavirus B Infection Drug Sales Market Share by Application in 2020
Figure 44. Southeast Asia Influenzavirus B Infection Drug Sales Market Share by Type in 2020
Figure 45. Southeast Asia Influenzavirus B Infection Drug Sales Market Share by Application in 2020
Figure 46. India Influenzavirus B Infection Drug Sales Market Share by Type in 2020
Figure 47. India Influenzavirus B Infection Drug Sales Market Share by Application in 2020
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Influenzavirus B Infection Drug
Figure 50. Manufacturing Process Analysis of Influenzavirus B Infection Drug
Figure 51. Influenzavirus B Infection Drug Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed